EARLY ALLOGRAFT DYSFUNCTION AND ACUTE KIDNEY INJURY AFTER LIVER TRANSPLANTATION: DEFINITIONS, RISK FACTORS AND CLINICAL SIGNIFICANCE
https://doi.org/10.15825/1995-1191-2012-4-93-102
Abstract
This review discusses issues related to intensive care in recipients of transplanted liver in the early postoperative period, with an emphasis on contemporary conditions and attitudes that are specific for this group of patients. Early allograft dysfunction (EAD) requires immediate diagnosis and appropriate treatment in case. The causes of the EAD and therapeutic tactics are discussed. Acute kidney injury (AKI) and renal failure are common in patients after transplantation. We consider etiology, risk factors, diagnosis and treatment guidelines for AKI. The negative impact of EAD and AKI on the grafts survival and recipients is demonstrated.
About the Authors
L. Y. MoysyukRussian Federation
V. N. Poptsov
Russian Federation
Y. G. Moysyuk
Russian Federation
References
1. Готье С.В., Константинов Б.А, Цирульникова О.М. Трансплантация печени: Руководство для врачей. М.: Медицинское информационное агентство, 2008. 246 с.
2. Загайнов В.Е. , Серегин А.А., Зайцев А.И. и др. «Син- дром обкрадывания» селезеночной артерии по- сле ортотопической трансплантации печени // Вест. транспл. и искусств. органов. 2011. Т. XIII. No 2. С. 87–94.
3. Копылова Ю.В., Поз Я.Л., Строков А.Г. и др. Острое повреждение почек: исторические аспекты и крите- рии диагностики // Вест. транспл. и искусств. орга- нов. 2010. Т. XII. No 1. С. 94–99.
4. Корнилов М.Н. Выбор методики кавальной рекон- струкции при ортотопической трансплантации пече- ни: Дис. ... канд. мед. наук. М., 2010. 126 с.
5. Попцов В.Н., Мойсюк Я.Г., Ухренков С.Г. и др. Не- отложные состояния при трансплантации печени // Вест. транспл. и искусств. органов. 2010. Т. XII. No 2. С. 10–13.
6. Хубутия М.Ш., Гуляев В.А., Зимина Л.Н. и др. Ком-
7. плексная оценка состояния печени после выполне-
8. ния лапаротомии у мультиорганных доноров // Вест.
9. транспл. и искусств. органов. 2012. Т. XIV. No 1.
10. С. 41–49.
11. Цирульникова О.М. Печень в ранние сроки после ее обширных резекций и трансплантации: Дис. ... д-ра мед. наук. М., 2004. 283 с.
12. Agarwal B., Shaw S., Hari M.S., Burroughs A.K., Daven- port A. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? // J. Hepatol. 2009. Vol. 51. P. 504–509.
13. Alkofer B., Samstein B., Guarrera J.V. et al. Extended- donor criteria liver allografts // Semin Liver Dis. 2006. Vol. 26. P. 221–233.
14. Asrani S.K., Kim W.R., Pedersen R.A. et al. Daclizumab induction therapy in liver transplant recipients with renal insufficiency // Aliment Pharmacol Ther. 2010. Vol. 32. P. 776–786.
15. Barri Y.M., Sanchez E.Q., Jennings L.W. et al. Acute kidney injury following liver transplantation: definition and outcome // Liver Transpl. 2009. Vol. 15. P. 475– 483.
16. Barshes N.R., Horwitz I.B., Franzini L. et al. Waitlist
17. mortality decreases with increased use of extended cri-
18. teria donor liver grafts at adult liver transplant centers // Am. J. Transplant. 2007. Vol. 7. P. 1265–1270.
19. Bekker J., Ploem S., de Jong K.P. Early hepatic artery thrombosis after liver transplantation: a systematic re- view of the incidence, outcome and risk factors // Am. J.
20. Transplant. 2009. Vol. 9. P. 746–757.
21. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevs-
22. ky P. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004. Vol. 8. P. R204–R212.
23. Ben-Ari Z., Weiss-Schmilovitz H., Sulkes J. et al. Serum cholestasis markers as predictors of early outcome after liver transplantation // Clin. Transplant. 2004. Vol. 18. P. 130–136.
24. Biancofiore G., Pucci L., Cerutti E. et al. Cystatin C as a marker of renal function immediately after liver trans- plantation // Liver Transpl. 2006. Vol. 12. P. 285–291.
25. Carton E.G., Plevak D.J., Kranner P.W. et al. Periopera- tive care of the liver transplant patient: part 2 // Anesth. Analg. 1994. Vol. 78. P. 382–399.
26. Cabezuelo J.B., Ramirez P., Acosta F. et al. Does the standard vs piggyback surgical technique affect the de- velopment of early acute renal failure after orthotopic liver transplantation? // Transplant Proc. 2003. Vol. 35. P. 1913–1914.
27. Cabezuelo J.B., Ramirez P, Rios A. et al. Risk factors of acute renal failure after liver transplantation // Kidney Int. 2006. Vol. 69. P. 1073–1080.
28. Cholongitas E., Shusang V., Germani G. et al. Long- term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporine // Clin. Transplant; doi:10.1111/j.1399– 0012.2010.01321.x.
29. Charlton M.R., Wall W.J., Ojo A.O. et al. Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation // Liver Transpl. 2009. Vol. 15. P. S1–S34.
30. Davenport A., Anker S.D., Mebazaa A. et al. ADQI 7: the clinical management of the cardio-renal syndromes: work group statements from the 7th ADQI consensus conference // Nephrol Dial. Transplant. 2010. Vol. 25. P. 2077–2089.
31. Davenport A., Farrington K. Dialysis dose in acute kid- ney injury and chronic dialysis // Lancet. 2010. Vol. 375. P. 705–706.
32. Davenport A. Continuous renal replacement therapies in patients with liver disease // Semin Dial. 2009. Vol. 22. P. 169–172.
33. Della-Guardia B., Almeida M.D, Meira-Filho S.P. et al. Antibodymediated rejection: hyperacute rejection reality in liver transplantation? A case report // Transplant Proc. 2008. Vol. 40. P. 870–871.
34. Deschenes M., Belle S.H., Krom R.A. et al. Early allo- graft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplanta- tion Database // Transplantation. 1998. Vol. 66. P. 302–310
35. Feng S., Goodrich N.P., Bragg-Gresham J.L. et al. Cha- racteristics associated with liver graft failure: the con- cept of a donor risk index // Am. J. Transplant. 2006. Vol. 6. P. 783–790.
36. Feng S. The dilemma of high-risk deceased donor livers: who should get them? // Liver Transplantation. 2010. Vol. 16. No 10 (Suppl 2). Р. 60–64.
37. Foxton M.R., Al-Freah M.A., Portal A.J. et al. Increased Model for End-Stage Liver Disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs // Liver Transpl. 2010. Vol. 16. P. 668–677.
38. Ferreira A.C., Nolasco F., Carvalho D. et al. Impact of RIFLE classification in liver transplantation // Clin. Transplant. 2010. Vol. 24. P. 394–400.
39. Figueras J., Sabate A., Fabregat J. et al. Hemodynamics during the anhepatic phase in orthotopic liver transplan- tation with vena cava preservation: a comparative stu- dy // Transplant Proc. 1993. Vol. 25. P. 2588–2589.
40. Fisher L.R., Henley K.S., Lucey M.R. Acute cellular rejection after liver transplantation: variability, morbi- dity, and mortality // Liver Transpl. Surg. 1995. Vol. 1. P. 10–15.
41. Gonzalez F.X., Rimola A., Grande L. et al. Predictive fac- tors of early postoperative graft function in human liver transplantation // Hepatology. 1994. Vol. 20. P. 565–573.
42. Hilmi I.A., Planinsic R.M. Con: venovenous bypass should not be used in orthotopic liver transplanta- tion // J. Cardiothorac Vasc Anesth. 2006. Vol. 20. P. 744–747.
43. Kidney Disease: Improving Global Outcomes (KDI- GO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int. In press.
Review
For citations:
Moysyuk L.Y., Poptsov V.N., Moysyuk Y.G. EARLY ALLOGRAFT DYSFUNCTION AND ACUTE KIDNEY INJURY AFTER LIVER TRANSPLANTATION: DEFINITIONS, RISK FACTORS AND CLINICAL SIGNIFICANCE. Russian Journal of Transplantology and Artificial Organs. 2012;14(4):93-102. (In Russ.) https://doi.org/10.15825/1995-1191-2012-4-93-102